Migraine Relief Acetaminophen 250mg recalled over labeling errors
- Recall date
- July 24, 2024
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Aurobindo Pharma USA, Inc. recalls Healthy Living — Migraine Relief Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets
- Brand / firm
- Aurobindo Pharma USA, Inc., Healthy Living
Why it was recalled
Device & Drug Safety - Mislabeling — Mislabeling
What was recalled
Migraine Relief Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Aurobindo Pharma USA, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurobindo Pharma USA, Inc., Healthy Living